Skip to main content

Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: $9.00 - $11.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading.
Market Cap168.37M
Revenue (ttm)n/a
Net Income (ttm)-7.13M
Shares Out16.84M
EPS (ttm)-0.42
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Price Targetn/a
Earnings Daten/a

About INTS

Intensity Therapeutics, Inc. is a clinical stage biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRx℠ discovery platform. Our platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Amphiphilic molecules have two distinct components: one part is soluble in water and ...

CEOLewis H. Bender
Stock ExchangeNASDAQ
Ticker SymbolINTS
Full Company Profile

Financial Performance

Financial Statements


Intensity Therapeutics IPO Registration Document (S-1)

Intensity Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC